Compare OPY & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPY | AORT |
|---|---|---|
| Founded | 1881 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 1996 | 1996 |
| Metric | OPY | AORT |
|---|---|---|
| Price | $104.65 | $26.88 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $49.40 |
| AVG Volume (30 Days) | 103.3K | ★ 507.1K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.65% | N/A |
| EPS Growth | 104.71 | ★ 165.62 |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $1,638,071,000.00 | $298,836,000.00 |
| Revenue This Year | N/A | $14.20 |
| Revenue Next Year | N/A | $11.20 |
| P/E Ratio | ★ N/A | $921.00 |
| Revenue Growth | 14.35 | ★ 18.01 |
| 52 Week Low | $63.81 | $19.16 |
| 52 Week High | $123.24 | $48.25 |
| Indicator | OPY | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 43.74 | 61.48 |
| Support Level | $103.14 | $19.49 |
| Resistance Level | $116.71 | $37.65 |
| Average True Range (ATR) | 4.46 | 0.93 |
| MACD | -0.90 | 0.25 |
| Stochastic Oscillator | 9.29 | 75.77 |
Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.